Cuijpers P, Cristea I A, Weitz E, Gentili C, Berking M
Department of Clinical, Neuro and Developmental Psychology,Vrije Universiteit Amsterdam,The Netherlands.
Department of Clinical Psychology and Psychotherapy,Babes-Bolyai University,Cluj-Napoca,Romania.
Psychol Med. 2016 Dec;46(16):3451-3462. doi: 10.1017/S0033291716002348. Epub 2016 Sep 23.
The effects of cognitive behavioural therapy of anxiety disorders on depression has been examined in previous meta-analyses, suggesting that these treatments have considerable effects on depression. In the current meta-analysis we examined whether the effects of treatments of anxiety disorders on depression differ across generalized anxiety disorder (GAD), social anxiety disorder (SAD) and panic disorder (PD). We also compared the effects of these treatments with the effects of cognitive and behavioural therapies of major depression (MDD).
We searched PubMed, PsycINFO, EMBASE and the Cochrane database, and included 47 trials on anxiety disorders and 34 trials on MDD.
Baseline depression severity was somewhat lower in anxiety disorders than in MDD, but still mild to moderate in most studies. Baseline severity differed across the three anxiety disorders. The effect sizes found for treatment of the anxiety disorders ranged from g = 0.47 for PD, g = 0.68 for GAD and g = 0.69 for SAD. Differences between these effect sizes and those found in the treatment of MDD (g = 0.81) were not significant in most analyses and we found few indications that the effects differed across anxiety disorders. We did find that within-group effect sizes resulted in significantly (p < 0.001) larger effect sizes for depression (g = 1.50) than anxiety disorders (g = 0.73-0.91). Risk of bias was considerable in the majority of studies.
Patients participating in trials of cognitive behavioural therapy for anxiety disorders have high levels of depression. These treatments have considerable effects on depression, and these effects are comparable to those of treatment of primary MDD.
焦虑症的认知行为疗法对抑郁症的影响已在以往的荟萃分析中进行了研究,结果表明这些疗法对抑郁症有显著效果。在本次荟萃分析中,我们研究了焦虑症治疗对抑郁症的影响在广泛性焦虑症(GAD)、社交焦虑症(SAD)和惊恐障碍(PD)之间是否存在差异。我们还将这些疗法的效果与重度抑郁症(MDD)的认知和行为疗法的效果进行了比较。
我们检索了PubMed、PsycINFO、EMBASE和Cochrane数据库,纳入了47项关于焦虑症的试验和34项关于MDD的试验。
焦虑症患者的基线抑郁严重程度略低于MDD患者,但在大多数研究中仍为轻度至中度。三种焦虑症的基线严重程度有所不同。焦虑症治疗的效应大小范围为:PD的g = 0.47,GAD的g = 0.68,SAD的g = 0.69。在大多数分析中,这些效应大小与MDD治疗的效应大小(g = 0.81)之间的差异不显著,并且我们几乎没有发现表明各焦虑症之间效应存在差异的迹象。我们确实发现,组内效应大小导致抑郁症的效应大小(g = 1.50)显著(p < 0.001)大于焦虑症(g = 0.73 - 0.91)。大多数研究中的偏倚风险相当大。
参与焦虑症认知行为疗法试验的患者有较高程度的抑郁。这些疗法对抑郁症有显著效果,且这些效果与原发性MDD治疗的效果相当。